Innowave MTB/RIF/INH facilitates timely and accurate diagnosis of multiple-drug resistant tuberculosis as a near POCT technique: a multicenter prospective on-site performance evaluation study
InnowaveDX is an easy, rapid, and sensitive molecular test for PTB diagnosis that can detect INH and RIF resistance within 3 h, facilitating MDR-TB diagnosis on the first day of hospital admission.
Authors
- Zhongfeng Cui
- Fen Wang (ORCID: https://orcid.org/0000-0002-4876-710X)
- Long Cai (ORCID: https://orcid.org/0009-0002-7361-0195)
- Hairong Huang (ORCID: https://orcid.org/0009-0003-5363-5536)
- Guanglu Jiang (ORCID: https://orcid.org/0000-0002-6967-552X)
Institutions
- Beijing Chest Hospital (CN)
- Hangzhou Red Cross Hospital (CN)
- The Sixth People's Hospital of Zhengzhou (CN)
Publication Details
- Journal
- Annals of Clinical Microbiology and Antimicrobials
- Published
- 2025-09-26
- DOI
- https://doi.org/10.1186/s12941-025-00822-7
- Primary Topic
- Tuberculosis Research and Epidemiology
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Key Research and Development Program of China